Search Results 101-110 of 17582 for cannabis
Positive toxicology screen for cannabis and cannabis use disorder by structured clinical interview. Participants who use cannabis for recreational or ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cenobamate; Ceritinib; Cetirizine; Chloral Hydrate. Show More. Other Interactions.
... Cannabis, and Illicit (Noncannabis) Drug Use Among a Large Sample of Transgender People in the United States. J Prim Prev. 2017 Aug; 38 (4):419-445. View ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Cariprazine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine ...
We help people with cannabis counseling, so we do a lot of that to help with symptom management, and if patients have indications we can certify them for ...
... cannabis on a case-by-case basis. History of drug use disorder over the past year, other than alcohol/nicotine/caffeine/cannabis. Plans to travel across ...
Patient is unwilling to abstain from using recreational or medicinal cannabis, or synthetic cannabinoid-based medications (including Sativex) during the study.
Is currently using recreational or medicinal cannabis, or synthetic cannabinoid based medications (including Sativex®) other than the investigational ...
History of marijuana/cannabis use (amount/ times per week). Excessive tobacco use (i.e. more than 10 cigarettes a day). Excessive alcohol (> 5 drinks daily ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!